Tag: precision medicine
Molecular Tumor Boards Reduce Death Risk by 13% in Cancer Patients, Meta-Analysis Shows
Comprehensive meta-analysis of 78 studies shows molecular tumor boards reduce cancer death risk by 13% and progression risk by 27%.…
Oxford Study Unravels Inflammatory Bowel Disease as Multiple Distinct Conditions
Oxford-led research reveals IBD comprises multiple distinct diseases with different mechanisms. Discovery opens pathway to targeted diagnostics and personalized treatment…
USC researchers identify enzyme target for reducing Alzheimer’s brain inflammation
USC researchers have identified a new approach to combat Alzheimer's by targeting the cPLA2 enzyme that drives brain inflammation. The…
UK Restricts Prostate Cancer Screening to High-Risk Men Only
UK health advisors restrict prostate cancer screening to men with dangerous genetic variants and family cancer histories. The targeted approach…
Medical Dosing Based on Race Lacks Scientific Evidence and May Harm Patients, NEJM Analysis Warns
New NEJM analysis challenges race-based medication dosing, arguing it lacks scientific foundation and may harm patients. Authors advocate for precision…
New Treatment Shows Promise Against Aggressive Jaw Tumour
Researchers report successful targeting of Wnt–β-catenin pathway in recurrent jaw tumour. New molecular approach offers hope for cases unsuitable for…
Digital Twins of Donor Lungs Could Transform Transplant Medicine
Researchers create digital twins of donor lungs using ex vivo perfusion data, enabling virtual testing of therapies and personalized transplant…
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access
Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned as five-year pancreatic cancer survival…